Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1995 Sep;63(9):3266–3271. doi: 10.1128/iai.63.9.3266-3271.1995

Purification and characterization of factors produced by Aspergillus fumigatus which affect human ciliated respiratory epithelium.

R Amitani 1, G Taylor 1, E N Elezis 1, C Llewellyn-Jones 1, J Mitchell 1, F Kuze 1, P J Cole 1, R Wilson 1
PMCID: PMC173450  PMID: 7543879

Abstract

The mechanisms by which Aspergillus fumigatus colonizes the respiratory mucosa are unknown. Culture filtrates of eight of nine clinical isolates of A. fumigatus slowed ciliary beat frequency and damaged human respiratory epithelium in vitro. These changes appeared to occur concurrently. Culture filtrates of two clinical isolates of Candida albicans had no effect on ciliated epithelium. We have purified and characterized cilioinhibitory factors of a clinical isolate of A. fumigatus. The cilioinhibitory activity was heat labile, reduced by dialysis, and partially extractable into chloroform. The activity was associated with both high- and low-molecular-weight factors, as determined by gel filtration on Sephadex G-50. A low-molecular-weight cilioinhibitory factor was further purified by reverse-phase high-performance liquid chromatography and shown by mass spectrometry to be gliotoxin, a known metabolite of A. fumigatus. Gliotoxin significantly slowed ciliary beat frequency in association with epithelial damage at concentrations above 0.2 microgram/ml; other Aspergillus toxins, i.e., fumagillin and helvolic acid, were also cilioinhibitory but at much higher concentrations. High-molecular-weight (> or = 35,000 and 25,000) cilioinhibitory materials had neither elastolytic nor proteolytic activity and remain to be identified. Thus, A. fumigatus produces a number of biologically active substances which slow ciliary beating and damage epithelium and which may influence colonization of the airways.

Full Text

The Full Text of this article is available as a PDF (241.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amitani R., Wilson R., Rutman A., Read R., Ward C., Burnett D., Stockley R. A., Cole P. J. Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium. Am J Respir Cell Mol Biol. 1991 Jan;4(1):26–32. doi: 10.1165/ajrcmb/4.1.26. [DOI] [PubMed] [Google Scholar]
  2. Binder R. E., Faling L. J., Pugatch R. D., Mahasaen C., Snider G. L. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore) 1982 Mar;61(2):109–124. doi: 10.1097/00005792-198203000-00005. [DOI] [PubMed] [Google Scholar]
  3. Buchanan D. R., Lamb D. Saprophytic invasion of infarcted pulmonary tissue by Aspergillus species. Thorax. 1982 Sep;37(9):693–698. doi: 10.1136/thx.37.9.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burnett D., Chamba A., Hill S. L., Stockley R. A. Effects of plasma, tumour necrosis factor, endotoxin and dexamethasone on extracellular proteolysis by neutrophils from healthy subjects and patients with emphysema. Clin Sci (Lond) 1989 Jul;77(1):35–41. doi: 10.1042/cs0770035. [DOI] [PubMed] [Google Scholar]
  5. Burnett D., Chamba A., Hill S. L., Stockley R. A. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet. 1987 Nov 7;2(8567):1043–1046. doi: 10.1016/s0140-6736(87)91476-0. [DOI] [PubMed] [Google Scholar]
  6. Chandler D. K., Barile M. F. Ciliostatic, hemagglutinating, and proteolytic activities in a cell extract of Mycoplasma pneumoniae. Infect Immun. 1980 Sep;29(3):1111–1116. doi: 10.1128/iai.29.3.1111-1116.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Currie D. C., Pavia D., Agnew J. E., Lopez-Vidriero M. T., Diamond P. D., Cole P. J., Clarke S. W. Impaired tracheobronchial clearance in bronchiectasis. Thorax. 1987 Feb;42(2):126–130. doi: 10.1136/thx.42.2.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Diamond R. D., Krzesicki R., Epstein B., Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. Am J Pathol. 1978 May;91(2):313–328. [PMC free article] [PubMed] [Google Scholar]
  9. Eichner R. D., Al Salami M., Wood P. R., Müllbacher A. The effect of gliotoxin upon macrophage function. Int J Immunopharmacol. 1986;8(7):789–797. doi: 10.1016/0192-0561(86)90016-0. [DOI] [PubMed] [Google Scholar]
  10. Eichner R. D., Waring P., Geue A. M., Braithwaite A. W., Müllbacher A. Gliotoxin causes oxidative damage to plasmid and cellular DNA. J Biol Chem. 1988 Mar 15;263(8):3772–3777. [PubMed] [Google Scholar]
  11. Feldman C., Anderson R., Kanthakumar K., Vargas A., Cole P. J., Wilson R. Oxidant-mediated ciliary dysfunction in human respiratory epithelium. Free Radic Biol Med. 1994 Jul;17(1):1–10. doi: 10.1016/0891-5849(94)90002-7. [DOI] [PubMed] [Google Scholar]
  12. Gefter W. B., Weingrad T. R., Epstein D. M., Ochs R. H., Miller W. T. "Semi-invasive" pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung. Radiology. 1981 Aug;140(2):313–321. doi: 10.1148/radiology.140.2.7255704. [DOI] [PubMed] [Google Scholar]
  13. Glimp R. A., Bayer A. S. Fungal pneumonias. Part 3. Allergic bronchopulmonary aspergillosis. Chest. 1981 Jul;80(1):85–94. doi: 10.1378/chest.80.1.85b. [DOI] [PubMed] [Google Scholar]
  14. HINSON K. F. W., MOON A. J., PLUMMER N. S. Broncho-pulmonary aspergillosis; a review and a report of eight new cases. Thorax. 1952 Dec;7(4):317–333. doi: 10.1136/thx.7.4.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hingley S. T., Hastie A. T., Kueppers F., Higgins M. L., Weinbaum G., Shryock T. Effect of ciliostatic factors from Pseudomonas aeruginosa on rabbit respiratory cilia. Infect Immun. 1986 Jan;51(1):254–262. doi: 10.1128/iai.51.1.254-262.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kanthakumar K., Taylor G., Tsang K. W., Cundell D. R., Rutman A., Smith S., Jeffery P. K., Cole P. J., Wilson R. Mechanisms of action of Pseudomonas aeruginosa pyocyanin on human ciliary beat in vitro. Infect Immun. 1993 Jul;61(7):2848–2853. doi: 10.1128/iai.61.7.2848-2853.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Lansley A. B., Sanderson M. J., Dirksen E. R. Control of the beat cycle of respiratory tract cilia by Ca2+ and cAMP. Am J Physiol. 1992 Aug;263(2 Pt 1):L232–L242. doi: 10.1152/ajplung.1992.263.2.L232. [DOI] [PubMed] [Google Scholar]
  18. Lehrer R. I., Jan R. G. Interaction of Aspergillus fumigatus Spores with Human Leukocytes and Serum. Infect Immun. 1970 Apr;1(4):345–350. doi: 10.1128/iai.1.4.345-350.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. McConnochie K., O'Sullivan M., Khalil J. F., Pritchard M. H., Gibbs A. R. Aspergillus colonization of pulmonary rheumatoid nodule. Respir Med. 1989 Mar;83(2):157–160. doi: 10.1016/s0954-6111(89)80235-5. [DOI] [PubMed] [Google Scholar]
  20. Mroueh S., Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest. 1994 Jan;105(1):32–36. doi: 10.1378/chest.105.1.32. [DOI] [PubMed] [Google Scholar]
  21. Mullins J., Seaton A. Fungal spores in lung and sputum. Clin Allergy. 1978 Sep;8(5):525–533. doi: 10.1111/j.1365-2222.1978.tb01506.x. [DOI] [PubMed] [Google Scholar]
  22. Müllbacher A., Waring P., Eichner R. D. Identification of an agent in cultures of Aspergillus fumigatus displaying anti-phagocytic and immunomodulating activity in vitro. J Gen Microbiol. 1985 May;131(5):1251–1258. doi: 10.1099/00221287-131-5-1251. [DOI] [PubMed] [Google Scholar]
  23. Nelson L. A., Callerame M. L., Schwartz R. H. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis. 1979 Oct;120(4):863–873. doi: 10.1164/arrd.1979.120.4.863. [DOI] [PubMed] [Google Scholar]
  24. ORIE N. G., DE VRIES G. A., KIKSTRA A. Growth of Aspergillus in the human lung. Aspergilloma and aspergillosis. Am Rev Respir Dis. 1960 Nov;82:649–662. doi: 10.1164/arrd.1960.82.5.649. [DOI] [PubMed] [Google Scholar]
  25. PEPYS J., RIDDELL R. W., CITRON K. M., CLAYTON Y. M., SHORT E. I. Clinical and immunologic significance of Aspergillus fumigatus in the sputum. Am Rev Respir Dis. 1959 Aug;80:167–180. doi: 10.1164/arrd.1959.80.2.167. [DOI] [PubMed] [Google Scholar]
  26. Read R. C., Roberts P., Munro N., Rutman A., Hastie A., Shryock T., Hall R., McDonald-Gibson W., Lund V., Taylor G. Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating. J Appl Physiol (1985) 1992 Jun;72(6):2271–2277. doi: 10.1152/jappl.1992.72.6.2271. [DOI] [PubMed] [Google Scholar]
  27. Read R. C., Rutman A. A., Jeffery P. K., Lund V. J., Brain A. P., Moxon E. R., Cole P. J., Wilson R. Interaction of capsulate Haemophilus influenzae with human airway mucosa in vitro. Infect Immun. 1992 Aug;60(8):3244–3252. doi: 10.1128/iai.60.8.3244-3252.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Robertson M. D., Seaton A., Milne L. J., Raeburn J. A. Suppression of host defences by Aspergillus fumigatus. Thorax. 1987 Jan;42(1):19–25. doi: 10.1136/thx.42.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Robinson B. W., Venaille T. J., Mendis A. H., McAleer R. Allergens as proteases: an Aspergillus fumigatus proteinase directly induces human epithelial cell detachment. J Allergy Clin Immunol. 1990 Nov;86(5):726–731. doi: 10.1016/s0091-6749(05)80176-9. [DOI] [PubMed] [Google Scholar]
  30. Rodriguez P. L., Carrasco L. Gliotoxin: inhibitor of poliovirus RNA synthesis that blocks the viral RNA polymerase 3Dpol. J Virol. 1992 Apr;66(4):1971–1976. doi: 10.1128/jvi.66.4.1971-1976.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Rutland J., Cole P. J. Non-invasive sampling of nasal cilia for measurement of beat frequency and study of ultrastructure. Lancet. 1980 Sep 13;2(8194):564–565. doi: 10.1016/s0140-6736(80)91995-9. [DOI] [PubMed] [Google Scholar]
  32. Schaffner A., Douglas H., Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest. 1982 Mar;69(3):617–631. doi: 10.1172/JCI110489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sleigh M. A., Blake J. R., Liron N. The propulsion of mucus by cilia. Am Rev Respir Dis. 1988 Mar;137(3):726–741. doi: 10.1164/ajrccm/137.3.726. [DOI] [PubMed] [Google Scholar]
  34. Steinfort C., Wilson R., Mitchell T., Feldman C., Rutman A., Todd H., Sykes D., Walker J., Saunders K., Andrew P. W. Effect of Streptococcus pneumoniae on human respiratory epithelium in vitro. Infect Immun. 1989 Jul;57(7):2006–2013. doi: 10.1128/iai.57.7.2006-2013.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sutton P., Newcombe N. R., Waring P., Müllbacher A. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun. 1994 Apr;62(4):1192–1198. doi: 10.1128/iai.62.4.1192-1198.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Tomlinson J. R., Sahn S. A. Aspergilloma in sarcoid and tuberculosis. Chest. 1987 Sep;92(3):505–508. doi: 10.1378/chest.92.3.505. [DOI] [PubMed] [Google Scholar]
  37. Trown P. W. Antiviral activity of N, N'-dimethyl-epidithiapiperazinedione, a synthetic compound related to the gliotoxins, LL-S88alpha and beta, chetomin and the sporidesmins. Biochem Biophys Res Commun. 1968 Nov 8;33(3):402–407. doi: 10.1016/0006-291x(68)90585-8. [DOI] [PubMed] [Google Scholar]
  38. Trown P. W., Bilello J. A. Mechanism of action of gliotoxin: elimination of activity by sulfhydryl compounds. Antimicrob Agents Chemother. 1972 Oct;2(4):261–266. doi: 10.1128/aac.2.4.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wilson R., Pitt T., Taylor G., Watson D., MacDermot J., Sykes D., Roberts D., Cole P. Pyocyanin and 1-hydroxyphenazine produced by Pseudomonas aeruginosa inhibit the beating of human respiratory cilia in vitro. J Clin Invest. 1987 Jan;79(1):221–229. doi: 10.1172/JCI112787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wood R. E., Wanner A., Hirsch J., Farrell P. M. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis. 1975 Jun;111(6):733–738. doi: 10.1164/arrd.1975.111.6.733. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES